Kelun-Biotech's Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors

3 days ago 2

Read Entire Article
  1. Homepage
  2. Personal Finance
  3. Kelun-Biotech's Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors

Related

BRW Announces Notification of Sources of Distributions

BRW Announces Notification of Sources of Distributions

6 hours ago 0
SABA Announces Notification of Sources of Distributions

SABA Announces Notification of Sources of Distributions

6 hours ago 0
DSS Inc. sells $1.95 million worth of Impact Biomedical shares

DSS Inc. sells $1.95 million worth of Impact Biomedical shar...

6 hours ago 0

Trending

1. tom hanks
2. san diego pooth
3. del halbfinale 2025
4. podcast
5. nino de angelo
6. adriana lima
7. ariana grande
8. george clooney
9. ingo zamperoni
10. simone thomalla

Popular

Dogecoin (DOGE) price set for 55% rally if this trend keeps up

Dogecoin (DOGE) price set for 55% rally if this trend keeps ...

2 days ago 46
Great Grandpa’s Off-Kilter Epiphanies Hit Home

Great Grandpa’s Off-Kilter Epiphanies Hit Home

2 days ago 21
Chappell Roan’s Complete Dating History

Chappell Roan’s Complete Dating History

2 days ago 14
‘We’re bullish on stablecoins,’ next-gen DeFi — Coinbase Ventures head

‘We’re bullish on stablecoins,’ next-gen DeFi — Coinbase Ven...

2 days ago 14
Ethereum’s Final Pectra Test Goes Live On Hoodi Network

Ethereum’s Final Pectra Test Goes Live On Hoodi Network

2 days ago 11
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions · Privacy Policy ·

© Cryptonomy 2025. All rights are reserved

×

🔍 AI Summary

Generating summary...